Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
via Google News
The Latest on: Shortages of life-saving drugs
- Pig-human transplants may be a misguided attempt to address the organ shortageon May 11, 2022 at 7:20 am
At the end of 2021, 57-year old David Bennett Sr. was bedridden and on life-support with irreversible heart failure. He was not eligible for a human heart transplant or an implanted mechanical heart ...
- Supply-Chain Snags Create Shortages Of Lifesaving Medical Supplies In U.S.on May 3, 2022 at 3:30 am
She says the list of shortages includes basics such as IV tubing and catheters ... according to the U.S. Food and Drug Administration. In this photo illustration, the Owens & Minor Healthcare logo is ...
- End Drug Shortages Alliance Announces Board of Directors, Mission, Vision Statements in First All-Member Meetingon May 3, 2022 at 3:00 am
The number of active drug shortages in the U.S. has remained above 200 since 2018. As a result, patients and prescribers in the U.S. face disruption in accessing medications, sometimes impacting ...
- White House expands access to life-saving COVID-19 drug Paxlovidon April 28, 2022 at 3:17 pm
The White House is making efforts to expand access to life-saving COVID drug Paxlovid, manufactured by Pfizer, which previously suffered from shortages yet which now is widely available in most parts ...
- Thanks to COVID-19, Drug Shortages Take Center Stageon April 26, 2022 at 1:35 pm
Instead of a prefilled syringe or 1 mL premixed vial of life-saving epinephrine in the code ... are pushing back against the new normal of drug shortages — and gaining traction amid a pandemic ...
- Pharma importers warn shortage of life-saving drugs fast-approachingon April 17, 2022 at 8:55 pm
With life-saving imported pharmaceuticals including vital drugs depleting in the State-run facilities leading to shortages, Sri Lanka Medical Association (SLMA) has warned the government on ...
- Hospital in Ethiopia's Tigray struggles to treat patientson April 16, 2022 at 2:21 am
Doctors at the flagship hospital in Ethiopia’s embattled Tigray region say patients are dying amid shortages of life-saving drugs and oxygen ADDIS ABABA, Ethiopia -- Patients at the flagship ...
- Hospital in Ethiopia's Tigray struggles to treat patientson April 14, 2022 at 12:22 am
ADDIS ABABA, Ethiopia -- Patients at the flagship hospital in Ethiopia's embattled Tigray region are dying amid shortages of life-saving drugs and oxygen, according to health officials.
- Sri Lanka doctors warn of ‘catastrophe’ as medicines run lowon April 12, 2022 at 1:12 am
Drugs to treat heart attacks and ... its staff in a March 29 memo to limit surgeries only to “life-threatening conditions” due to shortages of neostigmine, a drug used by anaesthetists.
- 17p GST, non-payment of refunds: Pharma sector warns of shortage of lifesaving drugson April 4, 2022 at 5:40 pm
However, if the refunds are not timely paid to the pharma industry, there would be severe shortage of medicines and life-saving drugs in the country, the PPMA chairman said. The industry demanded ...
via Bing News